On April 16, 2025, Zenas BioPharma was sued for violations of the federal securities laws in the United States District Court for the District of Massachusetts on behalf of investors who purchased or otherwise acquired Zenas BioPharma securities pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with Zenas BioPharma’s September 2024 initial public offering (the “IPO” or “Offering”).

On April 11, 2025, BigBear.ai Holdings, Inc. was sued for violations of the federal securities laws in the United States District Court for the Eastern District of Virginia on behalf of investors who purchased or otherwise acquired BigBear securities between March 31, 2022 and March 25, 2025, both dates inclusive (the “Class Period”).

On April 11, 2025, Treace Medical Concepts, Inc. was sued for violations of the federal securities laws in the United States District Court for the Middle District of Florida on behalf of investors who purchased or otherwise acquired Treace Medical securities between May 8, 2023, and May 7, 2024, inclusive (the “Class Period”).

On April 4, 2025, Canopy Growth Corporation was sued for violations of the federal securities laws in the United States District Court for the Eastern District of New York on behalf of investors who purchased or otherwise acquired Canopy securities between May 30, 2024 and February 6, 2025, both dates inclusive (the “Class Period”).

On April 4, 2025, Everus Construction Group, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired Everus common stock between October 31, 2024 and February 11, 2025, inclusive (the “Class Period”), including investors who held MDU Resources Group, Inc. (“MDU Resources”) common stock as of October 21, 2024 and acquired Everus common stock issued in connection with the spinoff of Everus Construction (defined below) on or about October 31, 2024 (the “Spinoff”).

On April 4, 2025, Viatris Inc. was sued for violations of the federal securities laws in the United States District Court for the Western District of Pennsylvania on behalf of investors who purchased or otherwise acquired Viatris securities between August 8, 2024, to February 26, 2025, inclusive (the “Class Period”).

On April 3, 2025, Cerevel Therapeutics Holdings, Inc. was sued for violations of the federal securities laws in the United States District Court for the District of Delaware on behalf of investors who (a) sold or otherwise disposed of the publicly-traded common stock of Cerevel during the period from October 11, 2023 through August 1, 2024, inclusive (the “Class Period”) and thus were damaged by Defendants’ violations of Section 10(b) of the Exchange Act (the “Fraud Claim Class”); (b) held shares of Cerevel as of the January 8, 2024 record date (“Record Date”) and were entitled to vote on the merger of Cerevel and AbbVie Inc. (“AbbVie”) and thus were damaged by Defendants’ violations of Section 14(a) of the Exchange Act (the “Proxy Claim Class”); and (c) sold shares of Cerevel stock contemporaneously with Bain Capital’s purchase of shares on or about October 16, 2023 and thus were damaged by Bain’s violations
of Section 20A of the Exchange Act (the “Insider Trading Claim Class,” and collectively with the Fraud Claim Class and the Proxy Claim Class, the “Class”).

On April 2, 2025, Bakkt Holdings, Inc.  was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired Bakkt securities between March 25, 2024 and March 17, 2025, inclusive (the “Class Period”).

On March 28, 2025, Solaris Energy Infrastructure, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of Texas on behalf of investors who purchased or otherwise acquired Solaris securities between July 9, 2024 and March 17, 2025, inclusive (the “Class Period”).

On March 28, 2025, SoundHound AI, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased or otherwise acquired SoundHound securities between May 10, 2024 and March 3, 2025, both dates inclusive (the “Class Period”).

On March 27, 2025, Actinium Pharmaceuticals, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise
acquired Actinium securities between October 31, 2022, and August 2, 2024, inclusive (the “Class Period”).

On March 24, 2025, Ultra Clean Holdings, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased or otherwise acquired Ultra Clean securities between May 6, 2024 to February 24, 2025, inclusive (the “Class Period”).

On March 21, 2025, Sana Biotechnology, Inc. was sued for violations of the federal securities laws in the United States District Court for the Western District of Washington on behalf of investors who purchased or otherwise acquired Sana securities between March 17, 2023 and November 4, 2024, both dates inclusive (the “Class Period”).

On March 21, 2025, Perpetua Resources Corp. was sued for violations of the federal securities laws in the United States District Court for the District of Idaho on behalf of investors who purchased or otherwise acquired Perpetua securities between April 17, 2024, to February 13, 2025, inclusive (the “Class Period”).

On March 20, 2025, Jervois Global Limited was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired the Company’s securities on or after July 5, 2021 until the trading halt on January 2, 2025 (being the date of the trading halt) (the Class Period), including securities traded on the Australian Securities Exchange (ASX), Over-the-Counter (OTC) market in the United States, and the Toronto Stock Exchange (TSX) in Canada (Class).

On March 20, 2025, Zynex, Inc. was sued for violations of the federal securities laws in the United States District Court for the istrict of Colorado on behalf of investors who purchased or otherwise acquired Zynex securities between March 13, 2023 to March 11, 2025, inclusive (the “Class Period”).

On March 14, 2025, The Bancorp, Inc. was sued for violations of the federal securities laws in the United States District Court for the District of Delaware on behalf of investors who purchased or otherwise acquired Bancorp securities between January 25, 2024 and March 4, 2025, inclusive (the “Class Period”).

On March 14, 2025, enCore Energy Corp. was sued for violations of the federal securities laws in the United States District Court for the Southern District of Texas on behalf of investors who purchased or otherwise acquired enCore securities between March 28, 2024 and March 2, 2025, inclusive (the “Class Period”).

On March 14, 2025, TFI International Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired TFI securities between April 26, 2024 and February 19, 2025, inclusive (the “Class Period”).

On March 13, 2025, Geron Corporation was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased or otherwise acquired Geron securities between June 7, 2024, to February 25, 2025, inclusive (the “Class Period”).